MABGENESIS
MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in human and animal fields.
MABGENESIS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2019-06-03
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.mabgenesis.com
Total Employee:
1+
Status:
Active
Total Funding:
277.5 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Current Employees Featured
Founder
Investors List
The Miyazaki Bank
The Miyazaki Bank investment in Series A - MabGenesis
SMBC Venture Capital
SMBC Venture Capital investment in Series A - MabGenesis
ANNIVERSAIRE
ANNIVERSAIRE investment in Series A - MabGenesis
Beyond Next Ventures
Beyond Next Ventures investment in Series A - MabGenesis
Beyond Next Ventures
Beyond Next Ventures investment in Seed Round - MabGenesis
Official Site Inspections
http://www.mabgenesis.com
- Host name: 151.101.1.195
- IP address: 151.101.1.195
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MabGenesis"
Providing best-in-class therapeutic monoclonal antibody drugs
MabGenesis Inc. is a biopharmaceutical startup that uses 30+ years of antibody research to provide first-in-class and best-in-class therapeutic monoclonal antibody drugs for humans and …See details»
抗体医薬のスペシャリスト - MabGenesis（マブジェネシス）
MabGenesis（マブジェネシス）株式会社は、30年以上に渡る国内アカデミアによる抗体研究を実用化し、ヒト及び動物領域でfirst-in-class、best-in-classの治療用モノクローナル抗体医薬 …See details»
MabGenesis - Crunchbase Company Profile & Funding
MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in human and animal fields. They have antibody library and monoclonal antibody isolation technology. With the provision of …See details»
(Press Release) Ceva Santé Animale Licenses MabGenesis’ …
Jun 4, 2024 · Ceva Santé Animale S.A. (“Ceva”) and MabGenesis Inc. (“MabGenesis”) announced today that Ceva has exercised its option to an exclusive and worldwide license to …See details»
MabGenesis Inc. - LinkedIn
We have the world’s highest quality antibody libraries (MOURA Libraries) in terms of functionality and completeness, as well as highly efficient monoclonal antibody isolation technology (IMPACT).See details»
MabGenesis Company Profile 2024: Valuation, Funding …
Operator of a biopharmaceutical company intended to develop therapeutic monoclonal antibody drugs for humans and animals.See details»
Collaboration with MabGenesis to discover and develop novel …
As a successful, family owned company we plan in generations. We work together globally and with integrity. Our FOCUS articulates who we are and what we strive for, why we exist, how …See details»
Boehringer Ingelheim announces collaboration with …
MabGenesis Inc. is a biopharmaceutical startup that delivers first-in-class and best-in-class therapeutic monoclonal antibodies for human and animals using technologies established by 30+ years of academic research.See details»
MabGenesis Inc. | YOKOHAMA STARTUP HUB | Yokohama Future …
Jul 18, 2018 · Utilizing antibody research results in academia, we provide first-in-class and best-in-class therapeutic monoclonal antibody drugs in the human and animal fields.Phage …See details»
MabGenesis - Products, Competitors, Financials, Employees, …
MabGenesis is a biopharmaceutical startup focused on the development and provision of therapeutic monoclonal antibodies for humans and animals. Use the CB Insights Platform to …See details»
MabGenesis株式会社 - MabGenesis（マブジェネシス）
MabGenesis株式会社は、長年に渡るアカデミアでの抗体研究成果を活用し、ヒト及び動物領域でfirst-in-class、best-in-classの治療用モノクローナル抗体医薬品を提供するstart-upバイオ …See details»
Boehringer Ingelheim announces collaboration with MabGenesis …
Jan 19, 2022 · Under the agreement, MabGenesis will apply its unique platform to the discovery of first-in-class candidate antibodies against targets of interest selected by Boehringer …See details»
MabGenesis - Contacts, Employees, Board Members, Advisors
MabGenesis is a biotechnology firm that provides therapeutic monoclonal antibody drugs.See details»
MabGenesis株式会社 | YOKOHAMA STARTUP HUB | 横浜未来機構
Https://mabgenesis.com/ アカデミアでの抗体研究成果を活用し、ヒト及び動物領域でfirst-in-class、best-in-classの治療用モノクローナル抗体医薬品を提供。 ファージ抗体ライブラ …See details»
News - MabGenesis
Apr 15, 2024 · MabGenesis will be attending the upcoming Bio international Convention in San Diego, USA, 3-6 June, 2024. MabGenesis is certified as one of the six Yokohama Chizai Mirai …See details»
宮崎大学発ベンチャー企業・MabGenesis社がアニマルヘルス分野 …
Jan 21, 2022 · MabGenesis社は、宮崎大学・森下和広先生と藤田医科大学の黒沢仁先生が長年の研究の蓄積として保有していたヒトや動物のファージディスプレイ抗体基盤技術をもとに起 …See details»
ヒト及び動物用抗体医薬品を開発するMabGenesisに追加出資
Dec 2, 2022 · Beyond Next Ventures株式会社（本社：東京都中央区、代表取締役社長：伊藤 毅、以下「当社」）は、MabGenesis株式会社（本社：神奈川県横浜市、代表取締役：新庄 勝 …See details»
Contact - MabGenesis
Contact us for more information on our monoclonal antibodies and how it can be licensed.See details»
Collaboration to develop monoclonal antibodies - Veterinary …
Jan 21, 2022 · Boehringer Ingelheim, a global leader in animal health, and MabGenesis, a private biopharmaceutical company headquartered in Yokohama, Japan, have announced that they …See details»
Discovery Pipeline - MabGenesis
MabGenesis’s pipeline of products includes several proprietary therapeutic mAbs targeting unique epitopes for oncology and autoimmune diseases.See details»